Sign Up for The Checkup

Get the latest news and updates from etectRX

    News

    Placeholder

    ALOHA! Adherence: ID-Cap™ Clinical Trial Research Presented at the 2024 Hawaii International Conference on System Sciences (HICSS)

    1/24/2024

    The ID-Cap™ System embarks on a promising journey in 2024, receiving continued praise from clinical trials. Researchers from Brigham and Women’s Hospital and Ohio State...

    Read More
    etectRx and The Village at Gainesville Announce  Intelligent Incontinence Care Collaboration

    etectRx and The Village at Gainesville Announce Intelligent Incontinence Care Collaboration

    11/13/2023

    Partnership Marks First Industry Use of Novel Disposable eBrief GAINESVILLE, Fla. (November 13, 2023) – etectRx™, Inc. (etectRx™), a privately held silicon-enabled digital health sensor...

    Read More
    ID Cap™ System Evolution: Introducing the Wrist-Worn Reader

    ID Cap™ System Evolution: Introducing the Wrist-Worn Reader

    11/6/2023

    The development of a Wrist-Worn Reader is the latest advancement to the ID-Cap™ System, offering a promising solution to address the complex issue of medication...

    Read More
    Global Growth: University of Cape Town Announces ID-Cap™ System Acceptability Study

    Global Growth: University of Cape Town Announces ID-Cap™ System Acceptability Study

    10/23/2023

    University of Cape Town announces ID-Cap™ System acceptability study in South Africa. Mass General Brigham in collaboration with University of Cape Town is conducting a...

    Read More
    ID-Cap™ System Powers Historic HIV Digital Pill Study

    ID-Cap™ System Powers Historic HIV Digital Pill Study

    10/9/2023

    etectRx announces record-breaking use of the ID-Cap™ System, utilized in University of Colorado’s HIV treatment study. The Quantification of Tenofovir Alafenamide Adherence and Exposure in...

    Read More
    Preliminary Analysis of Real-Time Therapy-Based Interventions with ID-Cap™ System Demonstrates Effectiveness of Maintaining Adherence for High-Risk Populations

    Preliminary Analysis of Real-Time Therapy-Based Interventions with ID-Cap™ System Demonstrates Effectiveness of Maintaining Adherence for High-Risk Populations

    8/28/2023

    NCT03512418- An ongoing study designed to evaluate PrEP adherence data using cognitive behavioral therapy based interventions delivered through the ID-Cap™ System in MSM (men who...

    Read More
    Placeholder

    Leading Digital Pill Solution Surpasses 10,000 Ingestions

    3/24/2023

    etectRx™, Inc. (etectRx™), the standard in FDA-cleared digital medication adherence, today announced that its digital pill, the ID-Cap System has surpassed 10,000 ingestions, a significant...

    Read More
    Placeholder

    Remote Therapy Monitoring Billing Guide

    3/24/2023

    In 2022 the Centers for Medicare and Medicaid Services (CMS) expanded its digital health coverage and began reimbursing providers for remote therapy monitoring (RTM). RTM...

    Read More
    Placeholder

    High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic

    3/24/2023

    COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from...

    Read More
    Placeholder

    Formative Acceptance of Ingestible Biosensors to Measure Adherence to TB Medications

    9/28/2022

    Tuberculosis (TB) represents a significant public health threat in India. Adherence to antitubercular therapy (ATT) is the key to reducing the burden of this infectious...

    Read More
    Placeholder

    AARDEX® Group Adds etectRx to their MEMS® Adherence Hardware Ecosystem

    4/29/2022

    The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the...

    Read More
    Placeholder

    Development of a Digital Pill and Respondent Behavioral Intervention (PrEPSteps) for HIV Pre-exposure Prophylaxis Adherence Among Stimulant Using Men Who Have Sex With Men

    9/7/2021

    Our ID-Cap™ System was recently utilized in a clinical study in Boston, MA resulting in a research report drafted by Principal Investigator Dr. Peter Chai...

    Read More